Challenges to Biosimilar Substitution—Reply
Hakim A, Ross JS. Challenges to Biosimilar Substitution—Reply. JAMA 2017, 318: 1186-1187. PMID: 28973611, DOI: 10.1001/jama.2017.11937.Commentaries, Editorials and LettersObstacles to the Adoption of Biosimilars for Chronic Diseases
Hakim A, Ross JS. Obstacles to the Adoption of Biosimilars for Chronic Diseases. JAMA 2017, 317: 2163-2164. PMID: 28459924, DOI: 10.1001/jama.2017.5202.Commentaries, Editorials and Letters